FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7314811000001102: Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20218501000001110 Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39117901000001117 Lisopress 10mg tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Product containing precisely lisinopril 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has active ingredient Lisinopril false Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Lisopress true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Is pack of False Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Lisopress 10mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start